CMRF-44 antibody-mediated depletion of activated human dendridic cells: A potential means for improving allograft survival

Transplantation

Volumn 75, Issue 10, 2003, Pages 1723-1730

  Koppi, Thelma ^a   Munster, David J ^b   Brown, Len ^b   MacDonald, Kelli P A ^b   Hart, Derek N J ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b MATER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; ANTIGEN; CD14 ANTIGEN; CD19 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD83 ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CMRF 44; UNCLASSIFIED DRUG;

ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOGRAFT; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOLYSIS; DENDRITIC CELL; FLOW CYTOMETRY; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TISSUE GRAFT;

ADJUVANTS, IMMUNOLOGIC; ANTIBODIES, MONOCLONAL; ANTIGENS; ANTIGENS, CD45; BLOOD PHYSIOLOGY; CD4-POSITIVE T-LYMPHOCYTES; CELL COUNT; CELL DEATH; CELL DIVISION; CELLS, CULTURED; COMPLEMENT SYSTEM PROTEINS; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; GRAFT SURVIVAL; HEMOCYANIN; HUMANS; MONOCYTES; OSMOLAR CONCENTRATION; TETANUS TOXOID;

EID: 0037674652     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000062569.40977.66     Document Type: Article

References (31)

1. Hart DNJ. Dendritic cells: Unique leucocyte populations which control the primary immune response. Blood 1997; 90(9): 3245.
2. Grouard G, Rissoan M-C, Filgueira L, et al. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med 1997; 185: 1101.
3. Hock BD, Starling GC, Daniel PB, et al. Characterisation of CMRF-44, a novel monoclonal antibody to an activation antigen expressed by the allostimulatory cells within peripheral blood, including dendritic cells. Immunology 1994; 83: 573.
4. Zhou LJ, Tedder TF. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J Immunol 1995; 154: 3821.
5. Fazekas de St Groth B. DCs and peripheral T cell tolerance. Semin Immunol 2001; 13(5): 311.
6. Steptoe RJ, Fu F, Li W, et al. Augmentation of dendritic cells in murine organ donors by Flt3 ligand alters the balance between transplant tolerance and immunity. J Immunol 1997; 159(11): 5483.
7. Thomson AW, Lu L. Are dendritic cells the key to liver transplant tolerance? Immunol Today 1999; 20(1): 27.
8. Penfield JG, Wang Y, Li S, et al. Transplant surgery injury recruits recipient MHC class II-positive leukocytes into the kidney. Kidney Int 1999; 56(5): 1759.
9. McKenzie JL, Beard MEJ, Hart DNJ. Effective depletion of donor dendritic cells prolongs rat cardiac allograft survival. Transplantation 1984; 38: 371.
10. McKenzie JL, Beard MEJ, Hart DNJ. Depletion of donor kidney dendritic cells prolongs graft survival. Transplant Proc 1984; 16(4): 948.
11. Faustman D, Steinman RM, Gebel H, et al. Prevention of rejection of murine islet allografts by pretreatment with anti-dendritic cell antibody. Proc Natl Acad Sci USA 1984; 81: 3864.
12. Shlomchik WD, Couzens MS, Tang CB, et al. Prevention of graft versus host disease by inactivation of host antigen- presenting cells. Science 1999; 285(5426): 412.
13. Fearnley DB, Whyte LF, Carnoutsos SA, et al. Monitoring human blood dendritic cell numbers in normal individuals and in stem cell transplantation. Blood 1999; 93(2): 728.
14. Arpinati M, Green CL, Heimfeld S, et al. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood 2000; 95(8): 2484.
15. Deeg HJ, Blazar BR, Bolwell BJ, et al. Treatment of steroid-refractory acute graft-versus-host disease with anti-CD147 monoclonal antibody ABX-CBL. Blood 2001; 98(7): 2052.
16. Cahn JY, Bordigoni P, Tiberghien P, et al. Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody: A multicenter phase III study. Transplantation 1995; 60(9): 939.
17. Koenen HJ, Joosten I. Blockade of CD86 and CD40 induces alloantigen-specific immunoregulatory T cells that remain anergic even after reversal of hyporesponsiveness. Blood 2000; 95(10): 3153.
18. Kirk AD, Burkly LC, Batty DS, et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat Med 1999; 5(6): 686.
19. Blazar BR, Taylor PA, Panoskaltsis-Mortari A, et al. Coblockade of the LFA1:ICAM and CD28/CLTA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts. Blood 1995; 85: 2607.
20. Gribben JG, Guinan EC, Boussiotis VA, et al. Complete blockade of B7 family-mediated costimulation is necessary to induce human alloantigen-specific anergy: A method to ameliorate graft-versus-host disease and extend the donor pool. Blood 1996; 87: 4887.
21. Fearnley DB, McLellan AD, Mannering SI, et al. Isolation of human blood dendritic cells using the CMRF-44 monoclonal antibody: Implications for studies on antigen presenting cell function and immunotherapy. Blood 1997; 89: 3708.
22. Ho CS, Lopez JA, Vuckovic S, et al. Surgical and physical stress increases circulating blood dendritic cell counts independently of monocyte counts. Blood 2001; 98(1): 140.
23. McLellan AD, Heiser A, Sorg RV, et al. Dermal dendritic cells associated with T lymphocytes in normal human skin display an activated phenotype. J Invest Dermatol 1998; 111(5): 841.
24. Lopez JA, Bioley G, Turtle C, et al. Single step isolation of blood DC by positive immunoselection. J Immunol Methods 2003; 274: 47.
25. Hock BD, Fearnley DB, Boyce A, et al. Human dendritic cells express a 95 kDa activation/differentiation antigen defined by CMRF-56. Tissue Antigens 1999; 53(4 pt 1): 320.
26. Rissoan M, Soumelis V, Kadowaki N, et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999; 283: 1183.
27. Cella M, Facchetti F, Lanzavecchia A, et al. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol 2000; 1(4): 305.
28. Clark GJ, Gunningham SP, Troy AJ, et al. Expression of the RelB transcription factor correlates with the activation of human dendritic cells. Immunology 1999; 98(2): 189.
29. Summers KL, Hock BD, McKenzie JL, et al. Phenotypic characterization of five dendritic cell subsets in human tonsils. Am J Pathol 2001; 159(1): 285.
30. Thomas JM, Contreras JL, Jiang XL, et al. Peritransplant tolerance induction in macaques: Early events reflecting the unique synergy between immunotoxin and deoxyspergualin. Transplantation 1999; 68(11): 1660.
31. Guinan EC, Boussiotis VA, Neuberg D, et al. Transplantation of anergic histoincompatible bone marrow allografts. N Engl J Med 1999; 340(22): 1704.